Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Mashup Score: 1

ash.confex.com

Oral and Poster Abstracts Oral 616. Acute Myeloid Leukemias: Investigational Therapies, Excluding Transplantation and Cellular Immunotherapies: Targeted Therapies and Novel Therapies Clinical Trials, Acute Myeloid Malignancies, Adults, AML, Clinical Research, Diseases, Therapies, Myeloid Malignancies, Study Population Curtis Lachowiez, MD1,...

  • 123456 Profile photo of Madelyn

    A phase 1b/2 study evaluating FLAG-IDA+VEN in 41 newly diagnosed AML patients had a 98% ORR (73% CR) and 66% went on to Allo. 39% had febrile neutropenia, 24% w/pneumonia and 19% bacteremia. There were 4 deaths all in the setting of relapsed disease.